Gastroenterologie up2date, Table of Contents Gastroenterologie up2date 2013; 09(01): 11-24DOI: 10.1055/s-0032-1326069 Ösophagus / Magen / Duodenum © Georg Thieme Verlag KG Stuttgart · New York Polypen und präkanzeröse Läsionen im Magen Herbert Koop , Esther Gatzky Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Park DY, Lauwers GY. Gastric polyps. Classification and management. Arch Pathol Lab Med 2008; 132: 633-640 2 Carmach SW, Genta RM, Schuler CM et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 2009; 104: 1524-1532 3 Jain R, Chetty R. Gastric hyperplastic polyps: a review. Dig Dis Sci 2009; 54: 1839-1846 4 Vieth M, Stolte M. Elevated risk for gastric adenocarcinoma can be predicted from histomorphology. World J Gastroenterol 2006; 12: 6109-6114 5 Seifert E, Gail K, Weismüller J. Gastric polypectomy. Long-term results (survey of 23 centres in Germany. Endoscopy 1983; 15: 8-11 6 Ohkusa T, Takashimizu I, Fujiki K et al. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med 1998; 129: 712-715 7 Cao H, Wang B, Zhang Z et al. Distribution trends of gastric polyps: an endoscopy database of 24121 northern Chinese patients. J Gastroenterol Hepatol 2012; 27: 1175-1180 8 Genta RM, Schuler CM, Ribiou CI et al. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study over 100,000 patients. Clin Gastroenterol Hepatol 2009; 7: 849-854 9 Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitors. Anat Pathol 2001; 116: 716-720 10 Biachi LK, Burke CA, Bennett AE et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2008; 6: 180-185 11 Torbenson M, Lee JH, Cruz-Correa M et al. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol 2002; 15: 718-723 12 Tytgat KMAJ. Upper gastrointestinal tumors. Endoscopy 2009; 42: 42-45 13 Kushima R, Vieth M. Das tubuläre Magenkarzinom. Mit Darstellung der Japanischen Kriterien unter Berücksichtigung des „pyloric gland adenoma“. Pathologe 2010; 31: 177-181 14 Hirota WK, Zuckerman WJ, Adler DG et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions in the upper GI tract. Gastrointest Endosc 2006; 63: 570-580 15 Pape UF, Anlauf M, Pavel M. Neuroendokrine Neoplasien des gastroenteropankreatischen Systems. Gastroenterologie up2date 2011; 7: 313-339 16 Delle Fave G, Kwekkeboom DJ, van Cutsem E et al. ENETS consensus guideline for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 2012; 95: 74-87 17 Stolte M, Finkenzeller G. Inflammatory fibroid polyp of the stomach. Endoscopy 1990; 22: 203-207 18 Schildhaus HU, Merkelbach-Bruse S, Binot E et al. Inflammatorischer fibroider Polyp. Von Vaneks „submukösem Granulom“ zum Konzept einer submukösen mesenchymalen Neoplasie. Pathologe 2010; 31: 109-114 19 Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O et al. Xantelasmas in the upper gastrointestinal tract. J Gastroenterol 2004; 39: 215-219 20 Brosens LAA, Langeveld D, van Hattem WA et al. Juvenile polyposis syndrome. World J Gastroenterol 2011; 17: 4839-4844 21 Oberhofer G, Stolte M. Gastric polyps: an update of their pathology and biological significance. Virchows Arch 2000; 437: 581-590 22 Correa P, Haenszel W, Cuello C et al. A model of gastric cancer epidemiology. Lancet 1975; 2: 58-60 23 den Hoed CM, van Eijck BV, Capelle LG et al. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer 2011; 47: 1211-1218 24 Fuccio L, Zagari RM, Eusebi LH et al. Meta-analysis: Can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?. Ann Intern Med 2009; 151: 121-128 25 Wong BC, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in a high risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194 26 Fukase K, Kato M, Kikuchi S et al. Effect of eradication of Helicobacter pylori on incidence of metachronous carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet 2008; 372: 392-397 27 Maehara Y, Nakamura S, Fijisawa K et al. Long-term effect of Helicobacter eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012; 75: 39-46 28 Dinis-Rebeiro M, Arela M, de Vries AC et al. Management of precancerous conditions and lesions in the stomach: guideline from the European Society for Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Protuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94 29 Fischbach W, Malfertheiner P, Hoffmann JC et al. S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit“ der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z Gastroenterol 2009; 47: 68-102 30 de Vries AC, van Griecken NCT, Looman CWN et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort sudy in the Netherlands. Gastroenterology 2008; 134: 945-952 31 Lambrecht NWG. Ménétrier’s disease of the stomach: a clinical challenge. Curr Gastroenterol Rep 2011; 13: 513-517 32 Coffey RJ, Washington MK, Corless CL et al. Ménétrier’s disease and gastrointestinal stroma tumors: hyperproliferative disorders of the stomach. J Clin Invest 2007; 117: 70-80
